AstraZeneca

AstraZeneca articles from Informachine.
AstraZeneca acquires EsoBiotec in $1 bn deal

AstraZeneca acquires EsoBiotec in $1 bn deal

18 Mar 2025

British-Swedish multinational pharmaceutical and biotechnology company AstraZenica on Monday announced the acquisition of biotechnology company EsoBiotech in a $1 billion transaction

AstraZeneca starts global recall of its controversial Covid 19 vaccine

AstraZeneca starts global recall of its controversial Covid 19 vaccine

08 May 2024

Days after admitting that its Covid 19 vaccine could cause blood clot in some people, British-Swedish pharmaceutical company AstraZeneca

AstraZeneca to buy China's Gracell Biotechnologies for $1.2 bn

AstraZeneca to buy China's Gracell Biotechnologies for $1.2 bn

27 Dec 2023

Anglo-Swedish multinational pharmaceutical and biotechnology company AstraZeneca has agreed to acquire China-based Gracell Biotechnologies Inc, for about $1.2 billion.

AstraZeneca to acquire CinCor Pharma in a deal worth $1,8 bn

11 Jan 2023

AstraZeneca to acquire biotech firm TeneoTwo in a deal worth more than $1.27 billion

08 Jul 2022

AstraZeneca to acquire Alexion in a $39 bn cash-and-stock deal

23 Dec 2020

India may grant emergency use authorisation for Oxford-AstraZeneca Covid-19 vaccine: report

24 Nov 2020

AstraZeneca Covid-19 vaccine trial volunteer in Brazil dies; testing to continue

26 Oct 2020

Sun Pharma licenses AstraZeneca to sell its oncology drugs in China

06 Nov 2019

AstraZeneca and Merck claim Japanese approval for anti-cancer drug Lynparza

20 Jun 2019

Stay ahead with Informachine News Trackers! Follow your selected sources, track business news with relevant keywords, and organize seamlessly using labels and bookmarks.

Get the business updates you need, fast, focused, and tailored just for you. Save time, stay informed, and never miss a beat!

Start your free subscription today!

Latest articles on AstraZeneca from Informachine

Imfinzi plus Imjudo combined with lenvatinib and TACE reduced the risk of disease progression or death by 30% in embolisation-eligible unresectable liver cancer in EMERALD-3 Phase III trial

01 Jun 2026

Imfinzi approved in the US in first and only immunotherapy combination for patients with BCG-naïve, high-risk non-muscle-invasive bladder cancer.

29 May 2026

US FDA decision date extended for SERENA-6 filing of camizestrant to enable review of additional data

27 May 2026

Datroway approved in the US as first TROP2-directed antibody drug conjugate for 1st-line treatment of patients with metastatic triple-negative breast cancer who are not PD-1/PD-L1 inhibitor candidates

22 May 2026

Enhertu recommended for approval in the EU by CHMP for patients with previously treated HER2-positive metastatic solid tumours

22 May 2026

Camizestrant in combination with a CDK4/6 inhibitor recommended for approval in the EU by CHMP for 1st-line advanced ER-positive breast cancer

22 May 2026

AstraZeneca to showcase Phase III data in liver, breast and bladder cancers and potential first-in-class rare disease therapy at ASCO 2026

22 May 2026

Baxfendy approved in the US as the first and only aldosterone synthase inhibitor treatment for adults with hypertension

18 May 2026

Enhertu approved in the US for two new indications for patients with HER2-positive early breast cancer

18 May 2026

Perioperative Imfinzi plus neoadjuvant EV showed statistically significant and clinically meaningful improvements in event-free survival and overall survival in muscle-invasive bladder cancer in the Phase III VOLGA trial

14 May 2026

Start your free subscription today!

View details about the software product Informachine News Trackers

Latest articles

Adani Green operationalises 3.37 GWh battery storage system at Khavda

 Adani Green operationalises 3.37 GWh battery storage system at Khavda

Transformers and Rectifiers wins ₹228 crore GETCO grid equipment order

 Transformers and Rectifiers wins ₹228 crore GETCO grid equipment order

Aditya Birla Capital plans ₹3,500 crore push to expand lending business

 Aditya Birla Capital plans ₹3,500 crore push to expand lending business

Bernstein says Adani’s funding stress phase has eased amid debt recovery

 Bernstein says Adani’s funding stress phase has eased amid debt recovery

Essar’s GreenLine scales LNG freight push with ₹1,500 crore expansion

 Essar’s GreenLine scales LNG freight push with ₹1,500 crore expansion

Indian Oil faces margin pressure as crude prices and shipping risks rise

 Indian Oil faces margin pressure as crude prices and shipping risks rise

SpaceX dual-class IPO revives debate over founder control and voting rights

 SpaceX dual-class IPO revives debate over founder control and voting rights

India accelerates ethanol and EV push as energy import bill climbs

 India accelerates ethanol and EV push as energy import bill climbs

Rising fuel costs pressure Swiggy and Zomato delivery margins

 Rising fuel costs pressure Swiggy and Zomato delivery margins